GLP-1 Therapy · Body & Weight · Brandon, FL
Physician-supervised GLP-1 therapy with semaglutide and tirzepatide, the most clinically effective weight loss medications ever approved, now available through Florida Aesthetics.
GLP-1 receptor agonists (semaglutide, tirzepatide) work by mimicking gut hormones that regulate hunger, insulin, and gastric emptying, reducing appetite, improving satiety, and facilitating significant weight loss through a biological mechanism rather than willpower alone.
Semaglutide (the active ingredient in Ozempic and Wegovy) and tirzepatide (Mounjaro, Zepbound) represent a new class of obesity medications with clinical outcomes that rival bariatric surgery. In clinical trials, patients on tirzepatide lost an average of 22% of body weight over 72 weeks, results previously only achievable through surgery.
At Florida Aesthetics, medical weight loss is supervised by our physician and includes monthly check-ins, dose titration, metabolic monitoring, and behavioral coaching. We don't simply write prescriptions, we provide the medical oversight, nutritional guidance, and accountability that makes sustainable weight loss achievable.
Physician-supervised programs using FDA-approved medications and evidence-based protocols.
FDA-approved GLP-1 receptor agonist. Average 15% body weight reduction in clinical trials. Weekly injection.
Learn More →Dual-action GIP/GLP-1 agonist showing up to 22% weight reduction in trials, the most effective FDA-approved option available.
Learn More →FDA-approved oral weight loss medication combining naltrexone and bupropion to reduce appetite and cravings.
Learn More →Weekly vitamin B12 and lipotropic MIC injections to boost energy, support metabolism, and enhance fat burning.
Learn More →Advanced body composition testing to measure fat mass, lean mass, and metabolic rate, the foundation of your personalized weight loss plan.
Learn More →Medical weight loss is a monthly subscription program that includes medication, physician oversight, lab interpretation, and behavioral support.
Starting dose (0.25mg/week)
per month
Dual GLP-1/GIP agonist
per month
Medication + body sculpting
per month (save on combo)
Prices do not include lab work (if not already on file). Insurance rarely covers medical weight loss at aesthetic practices, Cherry financing available.
Unretouched photos from real Florida Aesthetics patients. Individual results vary.
Individual results vary. All photos are unretouched and represent typical outcomes.
Understanding the landscape of medical weight management.
| Option | Semaglutide | Tirzepatide | Bariatric Surgery |
|---|---|---|---|
| Mechanism | GLP-1 receptor agonist | Dual GLP-1/GIP agonist | Anatomical restriction/malabsorption |
| Avg. weight loss | 15% body weight | 22% body weight | 30–40% (sleeve/bypass) |
| FDA approved | ✓ Yes (Wegovy 2021) | ✓ Yes (Zepbound 2023) | Procedures vary |
| Invasiveness | Weekly injection (non-surgical) | Weekly injection (non-surgical) | Major surgery |
| Side effects | GI nausea, possible hair loss | GI nausea (slightly more) | Significant surgical risks |
| Reversible | ✓ Yes (stop medication) | ✓ Yes (stop medication) | Partially (some procedures) |
| At FA | ✓ Yes | ✓ Yes | Not offered |
Ready to Book?
We'll evaluate your goals, explain exactly what Medical Weight Loss can and can't achieve for you, and provide a personalized treatment plan with transparent pricing.